Recognizing thrombotic thrombocytopenic purpura (TTP) in a woman with lupus and starting combined treatment — Cablivi (caplacizumab) on…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsBlood clots in spleen were unusual first sign in case of acquired TTP
A young man with unusual blood clots in the spleen was ultimately diagnosed with immune-mediated thrombotic thrombocytopenic purpura (TTP)…
VON WILLEBRAND DISEASE
NewsRare bleeding disorder meets clotting gene in unusual case
The rare coexistence of von Willebrand disease (VWD) type 3 and factor V Leiden (FVL) can…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsCOVID-19 in Canada linked to clotting problems but not TTP
The number of cases of the blood disorder thrombotic thrombocytopenic purpura (TTP) did not increase during the pandemic, but…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsCOVID-19 triggers difficult-to-treat TTP in pregnancy for woman, 41
COVID-19 may trigger or worsen refractory, or difficult-to-treat, thrombotic thrombocytopenic purpura (TTP) during the first months of pregnancy, requiring…
IMMUNE THROMBOCYTOPENIA
NewsANA-positive ITP linked to higher autoimmune disease risk
Patients with immune thrombocytopenia (ITP) who test positive for antinuclear antibodies (ANA), which mistakenly target the nucleus of cells,…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsAdzynma safely cuts relapse risk in TTP patients, new study finds
The preventive treatment Adzynma (recombinant human ADAMTS13) is safe and effective at reducing disease relapses for people with congenital…
IMMUNE THROMBOCYTOPENIA
NewsTailored blood thinning helps man, 65, with ITP, recurrent strokes
A man in his 60s with immune thrombocytopenia (ITP) experienced repeated strokes even while taking anticoagulant medications — commonly…
VON WILLEBRAND DISEASE
NewsResearch finds bleeding severity varies widely in type 2 VWD
The severity of bleeding in type 2 von Willebrand disease (VWD) can vary widely between subtypes and even among…
IMMUNE THROMBOCYTOPENIA
News1st BTK inhibitor rilzabrutinib, now Wayrilz, approved in US for ITP
Note: This story was updated Sept. 2, 2025, to clarify the definition of a durable platelet response used in LUNA…